Dr. Susan E. Bates
Claim this profileJames J Peters VA Medical Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
8 reported clinical trials
17 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage I
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Susan E. Bates is currently running
Peposertib + Avelumab + Radiation
for Hepatobiliary Cancer
This phase I/II trial studies the best dose and side effects of peposertib and to see how well it works with avelumab and hypofractionated radiation therapy in treating patients with solid tumors and hepatobiliary malignancies that have spread to other places in the body (advanced/metastatic). Peposertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects. Giving peposertib in combination with avelumab and hypofractionated radiation therapy may work better than other standard chemotherapy, hormonal, targeted, or immunotherapy medicines available in treating patients with solid tumors and hepatobiliary malignancies.
Recruiting1 award Phase 1 & 210 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
More about Susan E. Bates
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Susan E. Bates has experience with
- Nab-paclitaxel
- Gemcitabine
- Gemcitabine Hydrochloride
- Pembrolizumab
- Pemetrexed
- Bethanechol
Breakdown of trials Susan E. Bates has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Adenocarcinoma
Intrahepatic Cholangiocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Susan E. Bates specialize in?
Susan E. Bates focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Susan E. Bates currently recruiting for clinical trials?
Yes, Susan E. Bates is currently recruiting for 3 clinical trials in Bronx New York. If you're interested in participating, you should apply.
Are there any treatments that Susan E. Bates has studied deeply?
Yes, Susan E. Bates has studied treatments such as Nab-paclitaxel, Gemcitabine, Gemcitabine Hydrochloride.
What is the best way to schedule an appointment with Susan E. Bates?
Apply for one of the trials that Susan E. Bates is conducting.
What is the office address of Susan E. Bates?
The office of Susan E. Bates is located at: James J Peters VA Medical Center, Bronx, New York 10468 United States. This is the address for their practice at the James J Peters VA Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.